| BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635Z-1024-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621Z-1025-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733and 231274Z-1026-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657and 231658Z-1027-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678Z-1028-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219Z-1029-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175Z-1030-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and 231645Z-1031-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706Z-1032-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 and 231704Z-1033-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251Z-1034-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758Z-1035-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672Z-1036-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231691 and 2316…Z-1037-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544Z-1038-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 23…Z-1039-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344Z-1040-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023Z-0110-2024 · MDB | Becton Dickinson & Co. | Recall | Oct 12, 2023FDA classification date |
| BD Synapsys Informatics Solution, Catalog Number 444150Z-2099-2023 · JQP | Becton Dickinson & Co. | Recall | Jul 6, 2023FDA classification date |
| BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, 30 Single Use Test Devices-
Intended for the in vitro, simultaneous qualitative de…Z-1682-2023 · QMN | Becton Dickinson & Co. | Recall | Jun 2, 2023FDA classification date |
| BD Kiestra InoqulA+ with BD Kiestra" InoqulA+" and BeA Software version 5.1 and 5.1.1 as part of the Icefall A platform.
An in vitro diagnostic m…Z-1415-2023 · JTC | Becton Dickinson & Co. | Recall | Apr 20, 2023FDA classification date |
| BBL Chocolate II Agar- IVD for the isolation and cultivation of Neisseria species.
Catalog (Ref) Number: 221267Z-0473-2023 · JTY | Becton Dickinson & Co. | Recall | Dec 9, 2022FDA classification date |
| BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the rapid identification and susceptibility of most aerobic and facultative anaero…Z-0232-2023 · LON | Becton Dickinson & Co. | Recall | Nov 14, 2022FDA classification date |
| BD Synapsys Microbiology Informatics Solution, Catalog Number 444150, Software Version 4.10Z-1018-2022 · JQP | Becton Dickinson & Co. | Recall | Apr 29, 2022FDA record creation date |
| BD Veritor Plus Analyzer - intended to provide rapid test results in near-patient settings.
Catalog Number: 256066Z-0630-2022 · PSZ | Becton Dickinson & Co. | Recall | Feb 9, 2022FDA classification date |